...

首页> 外文期刊>European journal of cancer: official journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR) >Evaluation of the relationship among Topoisomerase II alpha expression, chemotherapeutic sensitivity, and prognostic factors in breast cancer

【24h】

Evaluation of the relationship among Topoisomerase II alpha expression, chemotherapeutic sensitivity, and prognostic factors in breast cancer

机译：乳腺癌中拓扑异构酶IIα表达，化疗敏感性和预后因素之间的关系评估

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《European journal of cancer: official journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)》 |2016年第2期|共1页
作者
Tokiniwa H.; Horiguchi J.; Takata D.; Nagaoka R.; Rokutanda N.; Sato A.; Higuchi T.; Obayashi-Uchida S.; Tsuboi M.; Takeyoshi I.; Oyama T.; Iino Y.;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类肿瘤学;
关键词

相似文献

外文文献
中文文献
专利

1. Evaluation of the relationship among Topoisomerase II alpha expression, chemotherapeutic sensitivity, and prognostic factors in breast cancer [J] . Tokiniwa H., Horiguchi J., Takata D., European journal of cancer: official journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR) . 2016,第Suppla2期

机译：乳腺癌中拓扑异构酶IIα表达，化疗敏感性和预后因素之间的关系评估
2. Evaluation of the prognostic role of centromere 17 gain and HER2/topoisomerase II alpha gene status and protein expression in patients with breast cancer treated with anthracycline-containing adjuvant chemotherapy: pooled analysis of two Hellenic Cooperative Oncology Group (HeCOG) phase III trials [J] . George Fountzilas, Urania Dafni, Mattheos Bobos, BMC Cancer . 2013,第1期

机译：评价含着蒽环类辅助化疗的乳腺癌患者着丝粒17的获得和HER2 /拓扑异构酶IIα基因状态及蛋白表达的预后作用：两项希腊合作肿瘤小组（HeCOG）III期临床试验的合并分析
3. Relationship between expression of topoisomerase II isoforms and intrinsic sensitivity to topoisomerase II inhibitors in breast cancer cell lines [J] . British Journal of Cancer . 1996,第7期

机译：拓扑异构酶II同工型的表达与乳腺癌细胞系对拓扑异构酶II抑制剂的内在敏感性之间的关系
4. Unveiling Fuzzy Associations Between Breast Cancer Prognostic Factors and Gene Expression Data [C] . F. Javier Lopez, Marta Cuadros, Armando Blanco, International Workshop on Database and Expert Systems Applications . 2009

机译：揭示乳腺癌预后因子和基因表达数据之间的模糊关联
5. Breast cancer-specific activation of topoisomerase IIalpha and its application in the tumor-targeting gene therapy. [D] . Day, Chi-Ping. 2005

机译：拓扑异构酶IIalpha的乳腺癌特异性激活及其在肿瘤靶向基因治疗中的应用。
6. Evaluation of the prognostic role of centromere 17 gain and HER2/topoisomerase II alpha gene status and protein expression in patients with breast cancer treated with anthracycline-containing adjuvant chemotherapy: pooled analysis of two Hellenic Cooperative Oncology Group (HeCOG) phase III trials [O] . George Fountzilas, Urania Dafni, Mattheos Bobos, 2013

机译：评价含着蒽环类辅助化疗的乳腺癌患者着丝粒17的获得和HER2 /拓扑异构酶IIα基因的状态及蛋白表达的预后作用：两项希腊合作肿瘤小组（HeCOG）III期临床试验的合并分析
7. Evaluation of the prognostic role of centromere 17 gain and HER2/topoisomerase II alpha gene status and protein expression in patients with breast cancer treated with anthracycline-containing adjuvant chemotherapy: pooled analysis of two Hellenic Cooperative Oncology Group (HeCOG) phase III trials [O] . 2013

机译：评价含着蒽环类辅助化疗的乳腺癌患者着丝粒17的获得和HER2 /拓扑异构酶IIα基因的状态及蛋白质表达的预后作用：两项希腊合作肿瘤小组（HeCOG）III期临床试验的合并分析

获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

客服微信
服务号